Adjuvant Technologies in the Construction of Advanced Vaccines

Por A. P. Semakova, N. I. Mikshis
Publicado em 2016-06-01

Ethical Principles for Handling Laboratory Animals in an Experiment with Pathogenic Biological Agents of the I-II Groups

Por V. G. Germanchuk, A. P. Semakova, N. Yu. Shavina
Publicado em 2018-12-01

LICENSED ANTHRAX VACCINES AND EXPERIMENTAL PREPARATIONS AT THE STAGE OF CLINICAL TRIALS

Por N. I. Mikshis, P. Yu. Popova, A. P. Semakova, V. V. Kutyrev
Publicado em 2017-08-01

Changes in Biomodels in Response to Recombinant Protective Anthrax Antigen Inoculation

Por P. Yu. Popova, S. A. Bugorkova, N. I. Mikshis, A. P. Semakova, Yu. A. Popov, T. N. Shchukovskaya
Publicado em 2013-12-01

Effectiveness of the “Sterius 60” SHF Radiation Installation for Disinfection of Objects Contaminated with PBA of Groups I–IV, when Working with Infected Biomodels

Por V. G. Germanchuk, A. P. Semakova, O. A. Lobovikova, M. V. Gordeeva, N. Yu. Shavina, K. M. Morozov, Z. L. Devdariani, N. P. Mironova
Publicado em 2021-02-01

Development of the scheme of obtaining antibodies to the ribonucleoprotein of attenuated rabies virus

Por Yu. K. Gavrilova, S. V. Generalov, M. N. Kireev, N. A. Sharapova, E. G. Abramova, L. V. Savitskaya, M. V. Ovchinnikova, T. Yu. Kirillova, A. P. Semakova
Publicado em 2019-11-01